Failure of Assay to Identify Low Cobalamin Concentrations (Letters) (Letter to the Editor) Failure of Assay to Identify Low Cobalamin Concentrations (Letters) (Letter to the Editor)

Failure of Assay to Identify Low Cobalamin Concentrations (Letters) (Letter to the Editor‪)‬

Clinical Chemistry 2000, Dec, 46, 12

Clinical Chemistry
    • $5.99
    • $5.99

Publisher Description

To the Editor: We wish to report a serious problem in the ADVIA:Centaur[R] chemiluminescence assay for cobalamin (Bayer Diagnostics; formerly the ACS:Centaur[R] assay, Chiron Diagnostics). The problem is urgent for two reasons: (a) our findings suggest that many cobalamin-deficient patients are being missed; and (b) the assay is used by increasing numbers of laboratories, which some time ago abandoned radioisotopic methods and were recently faced with the withdrawal of widely used assays by Abbott Laboratories.

GENRE
Science & Nature
RELEASED
2000
December 1
LANGUAGE
EN
English
LENGTH
9
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
165.3
KB

More Books Like This

Bias and Random Error in Retinol Measurements of Laboratories in Countries with Populations with Mild to Severe Vitamin A Deficiency (Technical Briefs) Bias and Random Error in Retinol Measurements of Laboratories in Countries with Populations with Mild to Severe Vitamin A Deficiency (Technical Briefs)
Bias and Random Error in Retinol Measurements of Laboratories in Countries with Populations with Mild to Severe Vitamin A Deficiency (Technical Briefs)
2002
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Why We Don't Know the Answer May Be More Important Than the Specific Question (Editorials) (Clinical Report) Why We Don't Know the Answer May Be More Important Than the Specific Question (Editorials) (Clinical Report)
Why We Don't Know the Answer May Be More Important Than the Specific Question (Editorials) (Clinical Report)
2004
Contemporary Practice in Clinical Chemistry Contemporary Practice in Clinical Chemistry
Contemporary Practice in Clinical Chemistry
2020
The Quality of Clinical Trials with Harpagophytum Procumbens (Review) The Quality of Clinical Trials with Harpagophytum Procumbens (Review)
The Quality of Clinical Trials with Harpagophytum Procumbens (Review)
2003
Statistical Issues in Drug Research and Development Statistical Issues in Drug Research and Development
Statistical Issues in Drug Research and Development
2017

More Books by Clinical Chemistry

Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report) Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey) Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
2007
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology) T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
2007
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers) Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998
High-Throughput Genotyping of Oncogenic Human Papilloma Viruses with MALDI-TOF Mass Spectrometry (Molecular Diagnostics and Genetics) High-Throughput Genotyping of Oncogenic Human Papilloma Viruses with MALDI-TOF Mass Spectrometry (Molecular Diagnostics and Genetics)
High-Throughput Genotyping of Oncogenic Human Papilloma Viruses with MALDI-TOF Mass Spectrometry (Molecular Diagnostics and Genetics)
2008